Register for SOSV Climate Tech Summit – Nov 3-7, 2025 (Virtual, Free). Learn More

GateHouse Bio (fka sRNAlytics)

An RNA therapeutic company

Team

David Salzman

CEO & Co-Founder

Neal Foster

Chief Product and Business Officer

Company details

When your cells make instructions in the form of mRNAs, there are also many small RNAs (sRNAs) that regulate those instructions. They regulate the health and disease of all living things, and researchers are now finding out that their activity patterns are indicative of overall patterns in the body.

Turns out, this is a good strategy for biomarker discovery. Gatehouse developed an RNA analytics platform intended to classify patient samples with binary accuracy. The company’s platform identifies small RNA biomarkers and discovers molecular pathways of disease through deep analysis of small RNAs and accelerates the development of targeted therapies, enabling custom bio-markers and companion diagnostics driving cures.

Get In Touch with GateHouse Bio (fka sRNAlytics)

Please tell us a little bit about yourself and why you'd like to get connected. GateHouse Bio (fka sRNAlytics) + SOSV will follow up with you via email.

Hidden
Hidden
Hidden
Hidden

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.